Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer
Status:
Completed
Trial end date:
2017-04-19
Target enrollment:
Participant gender:
Summary
The purpose of this open label, two stage, phase II study is to evaluate the efficacy and
tolerability of ZD6474 in patients with locally advanced or metastatic hereditary medullary
thyroid carcinoma.